Prochlorperazine Dosing Recommendations
For nausea and vomiting, prochlorperazine should be dosed at 10 mg orally every 4-6 hours as needed, with a maximum daily dose of 40 mg; for psychiatric conditions including schizophrenia, start with 5-10 mg orally 3-4 times daily and titrate to 100-150 mg daily for severe cases. 1
Antiemetic Use (Nausea and Vomiting)
Standard Dosing for Adults
- Oral tablets: 5-10 mg orally 3-4 times daily 1
- Maximum daily dose: 40 mg per day for resistant cases 1
- Alternative dosing: 10 mg every 4-6 hours as needed 2
- Rectal suppository: 25 mg every 12 hours 2
- Intravenous route: 2.5-5 mg IV push over one minute provides rapid relief (mean time to cessation of vomiting 8.5 minutes) 3
Context-Specific Applications
Chemotherapy-induced nausea (low to moderate emetogenic risk):
- 10 mg orally pretreatment (optional) 2
- 10 mg orally every 6 hours as needed for breakthrough symptoms 2
- Can be given intravenously at similar doses if oral route unavailable 2
Opioid-induced nausea prevention:
- 5 mg orally twice daily when initiating oxycodone reduces nausea incidence to 18.1% 4
- 10-15 mg/day orally for prevention, though carries 14% risk of extrapyramidal symptoms (specifically akathisia within one week) 5
Emergency department acute vomiting:
- 2.5 mg IV push initially; repeat once after 20 minutes if no response 3
- 10 mg IV provides superior efficacy compared to promethazine (9.5% vs 31% treatment failure rate) 6
Pediatric Dosing (≥2 years and ≥20 lbs)
Weight-based dosing for nausea/vomiting 1:
- 20-29 lbs: 2.5 mg 1-2 times daily (max 7.5 mg/day)
- 30-39 lbs: 2.5 mg 2-3 times daily (max 10 mg/day)
- 40-85 lbs: 2.5 mg 3 times daily or 5 mg twice daily (max 15 mg/day)
- Duration: More than one day's therapy seldom necessary 1
Psychiatric Use
Non-Psychotic Anxiety
- Dose: 5 mg orally 3-4 times daily 1
- Maximum: Do not exceed 20 mg per day 1
- Duration: Do not use longer than 12 weeks 1
Schizophrenia and Psychotic Disorders
Mild conditions (outpatient):
- Start: 5-10 mg orally 3-4 times daily 1
Moderate to severe conditions (hospitalized patients):
- Start: 10 mg orally 3-4 times daily 1
- Increase gradually by small increments every 2-3 days 1
- Target range: 50-75 mg daily for satisfactory response 1
- Optimal dose for severe disturbances: 100-150 mg daily 1
Pediatric schizophrenia (ages 2-12):
- Start: 2.5 mg 2-3 times daily 1
- Maximum first day: 10 mg 1
- Ages 2-5: Total daily dose usually does not exceed 20 mg 1
- Ages 6-12: Total daily dose usually does not exceed 25 mg 1
Special Populations and Precautions
Elderly Patients
- Use lower dosage ranges 1
- More susceptible to hypotension and neuromuscular reactions 1
- Titrate more gradually and monitor closely 1
Critical Safety Considerations
Extrapyramidal symptoms:
- Occur in 14% of patients receiving 10-15 mg/day for antiemetic purposes 5
- Akathisia typically appears within one week 5
- Children are more prone to extrapyramidal reactions even on moderate doses 1
- Use lowest effective dosage in pediatric patients 1
Contraindications in children:
- Do not use in pediatric surgery 1
- Avoid in children with acute illnesses or dehydration (increased dystonia risk) 1
- Do not use if child shows restlessness or excitement 1
Bioavailability advantage:
- Buccal administration produces plasma concentrations more than twice as high as oral tablets with less than half the variability 7
- Exposure to metabolites is approximately half that of oral tablets 7
Comparative efficacy: